<!--https://www.openaustralia.org.au/debates/?id=2018-11-27.26.1-->
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
 <head>
  <meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
  <title>
   Diabetes: 27 Nov 2018: House debates (OpenAustralia.org)
  </title>
  <meta content="Making parliament easy." name="description"/>
  <meta content="Parliament, government, House of Representatives, Senate, Senator, MP, Member of Parliament, MPs, Australia, Australian, Diabetes: 27 Nov 2018" name="keywords"/>
  <meta content="5FBaCDi8kCKdo4s64NEdB5EOJDNc310SwcLLYHmEbgg=" name="verify-v1"/>
  <meta content="width=device-width; initial-scale=1.0; maximum-scale=1.0" name="viewport">
   <link href="mailto:contact@openaustralia.org" rel="author" title="Send feedback"/>
   <link href="http://www.openaustralia.org.au/" rel="home" title="Home"/>
   <link href="/" rel="start" title="Home"/>
   <!-- skin: mobile -->
   <link href="/style/default/global_non_ns4_mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/mobile.css" rel="stylesheet" type="text/css"/>
   <link href="/style/default/print.css" media="print" rel="stylesheet" type="text/css"/>
   <script type="text/javascript">
    var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
   </script>
   <script type="text/javascript">
    var pageTracker = _gat._getTracker("UA-3107958-3");
pageTracker._initData();
pageTracker._trackPageview();
   </script>
  </meta>
 </head>
 <body>
  <div id="container">
   <a name="top">
   </a>
   <div id="banner">
    <div id="title">
     <h1>
      <a href="/" title="To the front page of the site">
       <img alt="OpenAustralia.org beta" height="32" src="/images/openaustraliaorgbeta.gif" width="262"/>
      </a>
     </h1>
    </div>
   </div>
   <!-- end #banner -->
   <div id="content">
    <div class="stripe-head-1">
     <div class="main">
      <h2>
       House debates
      </h2>
      <h3>
       Tuesday, 27 November 2018
      </h3>
      <h4>
       Statements by Members
      </h4>
      <h5>
       Diabetes
      </h5>
      <p>
       1:40 pm
      </p>
      <a name="g26.2">
      </a>
      <p class="speaker">
       <a href="/mp/?m=663" title="See more information about Ian Goodenough">
        <img alt="Photo of Ian Goodenough" class="portrait" src="/images/mps/10804.jpg"/>
        <strong>
         Ian Goodenough
        </strong>
       </a>
       <small>
        (Moore, Liberal Party) |
        <a href="http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;adv=yes;orderBy=_fragment_number,doc_date-rev;page=0;query=Dataset%3Ahansardr,hansardr80%20Date%3A27%2F11%2F2018;rec=0;resCount=Default" title="The source of this piece of text">
         Hansard source
        </a>
        <!-- | <script type="text/javascript" src="http://parlvid.mysociety.org/video.cgi?gid=2018-11-27.26.2&output=js-link"></script> -->
       </small>
       <p>
        There are 130,000 Australians with type 1 diabetes. It is a condition that is growing at the rate of 3,500 patients per year and affects many people in my electorate of Moore. I welcome the announcement by the health minister this week that the federal government will invest an extra $100 million over four years to support patients with type 1 diabetes by making continuous glucose monitoring devices available to more than 37,000 Australians. This new initiative will save families up to $7,000 per year. From 1 March 2019, eligibility for fully subsidised continuous glucose monitoring devices will be expanded under the National Diabetes Services Scheme to include: women with type 1 diabetes while pregnant, breastfeeding or actively planning a pregnancy; people with type 1 diabetes who are 21 years or older who have concessional status and who have high clinical need, such as those experiencing recurrent severe hypoglycemic events; children and young people with conditions similar to type 1 diabetes who require insulinâ€”this includes a range of conditions, such as cystic fibrosis related diabetes or neonatal diabetes. Expanding access to these glucose monitoring devices may offer many other health benefits, including reducing stress and anxiety.
       </p>
       <br/>
       <br/>
       <br/>
       <br/>
       <div id="footer">
        <p>
         <a href="/?show_pc">
          View the PC OA website
         </a>
        </p>
       </div>
      </p>
     </div>
    </div>
   </div>
  </div>
 </body>
</html>
